
Click
here to make a Legal complaint 
Avonex
(Interferon beta-1a) Audience: Neurologists and other healthcare professionals
Biogen and FDA revised the WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT
INFORMATION, and CLINICAL STUDIES sections of the prescribing information to include
important new safety information and a patient Medication Guide. Updated safety
information includes a cautionary note regarding use in patients with depression
and other severe psychiatric symptoms. Post-marketing reports of depression,
suicidal ideation and/or development of new or worsening of pre-existing psychiatric
disorders, including psychosis, and reports of anaphylaxis, pancytopenia, thrombocytopenia,
autoimmune disorders of multiple target organs, and hepatic injury manifesting
itself as elevated serum enzyme levels and hepatitis were added to the labeling. An
FDA-approved Patient Medication Guide, providing important patient safety information
and comprehensive instructions for patient self-administration of Avonex, was
added. ARAVA
AVANDIA BAYCOL
BEXTRA DISABILITY
ENBREL EPHEDRA
FEN-PHEN LARIAM
LOTRONEX MERIDIA
MEDICAL
INSURANCE FRAUD MEDICAL
LAWSUITS NORPLANT
NURSNG HOME
NEGLIGENCE OXYCONTIN PPA
PERMAX PREMPRO
PROPULSID REMICADE
REZULIN RISPERDAL
SERZONE SILICOSIS
STADOL SULZER
STROKE THIMEROSAL
MERCURY AUTISM VIOXX
WELDING FUMES
WRONGFUL DEATH |